These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9447945

  • 21. Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.
    Seifarth C, Mack M, Steinlicht S, Hahn EG, Lohmann T.
    Horm Metab Res; 2006 Mar; 38(3):167-71. PubMed ID: 16673207
    [Abstract] [Full Text] [Related]

  • 22. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
    Füchtenbusch M, Larger E, Thebault K, Boitard C.
    Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
    [Abstract] [Full Text] [Related]

  • 23. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A, Suarez WL, Power RF.
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [Abstract] [Full Text] [Related]

  • 24. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P.
    Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P, Ji RC, Shimoda H, Miura M, Kato S.
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [Abstract] [Full Text] [Related]

  • 29. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [Abstract] [Full Text] [Related]

  • 30. MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Panerai AE, Nicoletti F, Sacedote P, Arvidsson L, Conget I, Gomis R, Bartorelli A, Sandler S.
    Diabetologia; 2001 Jul; 44(7):839-47. PubMed ID: 11508268
    [Abstract] [Full Text] [Related]

  • 31. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.
    Katz J, Benoist C, Mathis D.
    Eur J Immunol; 1993 Dec; 23(12):3358-60. PubMed ID: 8258349
    [Abstract] [Full Text] [Related]

  • 32. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
    Nakazawa T, Satoh J, Takahashi K, Sakata Y, Ikehata F, Takizawa Y, Bando SI, Housai T, Li Y, Chen C, Masuda T, Kure S, Kato I, Takasawa S, Taniguchi T, Okamoto H, Toyota T.
    J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
    [Abstract] [Full Text] [Related]

  • 33. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.
    Vaccine; 2006 Jun 05; 24(23):5036-46. PubMed ID: 16621191
    [Abstract] [Full Text] [Related]

  • 34. Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study.
    Timsit J, Debray-Sachs M, Boitard C, Bach JF.
    Clin Exp Immunol; 1988 Aug 05; 73(2):260-4. PubMed ID: 3052943
    [Abstract] [Full Text] [Related]

  • 35. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 36. Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus.
    Ma YJ, Lu Y, Hou J, Dong YK, Du MZ, Xing Y, Ge CY, Xu ML, Jin L, Cao RY, Li TM, Wu J, Liu JJ.
    Int Immunopharmacol; 2011 Sep 01; 11(9):1298-302. PubMed ID: 21530685
    [Abstract] [Full Text] [Related]

  • 37. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
    Rohane PW, Shimada A, Kim DT, Edwards CT, Charlton B, Shultz LD, Fathman CG.
    Diabetes; 1995 May 01; 44(5):550-4. PubMed ID: 7729614
    [Abstract] [Full Text] [Related]

  • 38. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.
    Smerdon RA, Peakman M, Hussain MJ, Vergani D.
    Immunology; 1993 Nov 01; 80(3):498-501. PubMed ID: 8288322
    [Abstract] [Full Text] [Related]

  • 39. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P, Bourgeois EA, Levescot A, Pham L, Riant E, Ahui ML, Damotte D, Gombert JM, Bayard F, Ohlsson C, Arnal JF, Herbelin A.
    Endocrinology; 2016 Jan 01; 157(1):258-67. PubMed ID: 26485613
    [Abstract] [Full Text] [Related]

  • 40. New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2.
    Signore A, Chianelli M, Ferretti E, Toscano A, Britton KE, Andreani D, Gale EA, Pozzilli P.
    Eur J Endocrinol; 1994 Oct 01; 131(4):431-7. PubMed ID: 7921233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.